Education
About Us
Working with TipRanks
Follow Us
Sectra AB Class B (DE:61L0)
FRANKFURT:61L0
61L0 Stock Chart & Stats
€23.06
€0.30(1.31%)
At close: 4:00 PM EST
€23.06
€0.30(1.31%)
Day’s Range― - ―
52-Week Range€16.01 - €33.52
Previous CloseN/A
Volume0.00
Average Volume (3M)5.00
Market Cap
€4.19B
Enterprise Value€43.46B
Total Cash (Recent Filing)€1.35B
Total Debt (Recent Filing)€109.51M
Price to Earnings (P/E)68.4
Beta0.44
Next Earnings
May 29, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding182,017,440
10 Day Avg. Volume0
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio3.22
Price to Book (P/B)29.81
Price to Sales (P/S)17.64
P/FCF Ratio70.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.72Price Target Upside-14.50% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.28
Revenue Forecast (FY)€303.70M
Bulls Say, Bears Say
Bulls Say
Rapid Revenue AccelerationA sustained large uplift in TTM revenue indicates strong demand and successful go-to-market execution across software licensing and services. Over 2–6 months this suggests expanding market penetration and higher recurring contract base that can compound future revenue.
High And Durable ProfitabilityConsistently strong operating and net margins point to pricing power, efficient cost structure, and scalable software-centric economics. These margins enable reinvestment in R&D and sales, supporting product leadership and durable cash generation over the medium term.
Conservative Balance Sheet And Strong ROEVery low leverage paired with high ROE gives financial flexibility to fund growth, pursue partnerships or acquisitions, and withstand downturns. The capital-light software model combined with strong equity returns supports sustainable strategic options.
Bears Say
Declining Free Cash FlowA notable TTM FCF decline signals working-capital or collection variability that can reduce internal funding for capex, R&D, or acquisitions. Over months this raises the chance of tighter near-term liquidity and greater reliance on operational execution to restore cash conversion.
Margin And Gross-Profit VariabilitySignificant year-to-year margin swings imply sensitivity to product mix, pricing pressure, or cost volatility. This undermines longer-term margin predictability, complicates forecasting and budgeting, and increases execution risk for sustaining high profitability.
High Expectations Leave Little Room For ErrorElevated profitability raises external expectations; any slowdown or execution miss could disproportionately impact perceived stability and capital access. Structurally, this increases downside risk over the medium term if growth or margin performance softens.
Sectra AB Class B News
61L0 FAQ
What was Sectra AB Class B’s price range in the past 12 months?
Sectra AB Class B lowest stock price was €16.01 and its highest was €33.52 in the past 12 months.
What is Sectra AB Class B’s market cap?
Sectra AB Class B’s market cap is €4.19B.
When is Sectra AB Class B’s upcoming earnings report date?
Sectra AB Class B’s upcoming earnings report date is May 29, 2026 which is in 74 days.
How were Sectra AB Class B’s earnings last quarter?
Sectra AB Class B released its earnings results on Mar 06, 2026. The company reported €0.075 earnings per share for the quarter, beating the consensus estimate of €0.056 by €0.019.
Is Sectra AB Class B overvalued?
According to Wall Street analysts Sectra AB Class B’s price is currently Overvalued.
Does Sectra AB Class B pay dividends?
Sectra AB Class B does not currently pay dividends.
What is Sectra AB Class B’s EPS estimate?
Sectra AB Class B’s EPS estimate is 0.08.
How many shares outstanding does Sectra AB Class B have?
Sectra AB Class B has 182,017,440 shares outstanding.
What happened to Sectra AB Class B’s price movement after its last earnings report?
Sectra AB Class B reported an EPS of €0.075 in its last earnings report, beating expectations of €0.056. Following the earnings report the stock price went up 12.564%.
Which hedge fund is a major shareholder of Sectra AB Class B?
Currently, no hedge funds are holding shares in DE:61L0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sectra AB Class B
Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. The Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; and project-based development, as well as offers security and threat analyses and system monitoring services for control systems in society's critical operations. The Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies, defense departments, energy companies. Sectra AB (publ) was incorporated in 1957 and is headquartered in Linköping, Sweden.
61L0 Stock 12 Month Forecast
Average Price Target
€19.72
▼(-14.50% Downside)
Technical Analysis
Getinge
―
Vitrolife AB
―
BICO Group AB Class B
―
CellaVision AB
―
Xvivo Perfusion AB
―
Options Prices
Currently, No data available
---